S.O. 6091(E) Dated 29.12.2025 BAN ON ORAL FORMULATIONS NIMESULIDE 100 MG IMMEDIATE RELEASE (NOTIFICATIONS)
S.O. 6091(E) Dated 29.12.2025 BAN ON ORAL FORMULATIONS NIMESULIDE 100 MG IMMEDIATE RELEASE
NOTIFICATIONS
Appointment of Registering Authority (NOTIFICATIONS)
Appointment of Registering Authority
Appointment of Registering Authority (NOTIFICATIONS) Read More »
DCGI directs drugs manufacturers to file safety & efficacy data on non-approved FDC formulation before 31st August 2013 (NOTIFICATIONS)
DCGI directs drugs manufacturers to file safety & efficacy data on non-approved FDC formulation before 31st August 2013
Upload GSR 1230 (E) Dated: 21/12/2018 (NOTIFICATIONS)
Upload GSR 1230 (E) Dated: 21/12/2018
Upload GSR 1230 (E) Dated: 21/12/2018 (NOTIFICATIONS) Read More »
Notification G.S.R. 669 (E) Dated: 28/10/2024 (NOTIFICATIONS)
Notification G.S.R. 669 (E) Dated: 28/10/2024
Notification G.S.R. 669 (E) Dated: 28/10/2024 (NOTIFICATIONS) Read More »
Official Gazette Government of Goa OM 13-09-2023-I PHD dated17.02.2025 (NOTIFICATIONS)
Official Gazette Government of Goa OM 13-09-2023-I PHD dated17.02.2025
Official Gazette Government of Goa OM 13-09-2023-I PHD dated17.02.2025 (NOTIFICATIONS) Read More »
SO 5663(E) -Nimesulide and its Formulations Prohibited for Animal Use (NOTIFICATIONS)
SO 5663(E) -Nimesulide and its Formulations Prohibited for Animal Use
SO 5663(E) -Nimesulide and its Formulations Prohibited for Animal Use (NOTIFICATIONS) Read More »
Final GSR 823(E) Amendment in rule 96 for mandating Bar code 17.11.2022 (NOTIFICATIONS)
Final GSR 823(E) Amendment in rule 96 for mandating Bar code 17.11.2022
Final GSR 823(E) Amendment in rule 96 for mandating Bar code 17.11.2022 (NOTIFICATIONS) Read More »
GSR 778 New Drugs and Clinical Trials (Third Amendment) Rules 2022 (NOTIFICATIONS)
GSR 778 New Drugs and Clinical Trials (Third Amendment) Rules 2022
GSR 778 New Drugs and Clinical Trials (Third Amendment) Rules 2022 (NOTIFICATIONS) Read More »